The 340B drug discount program is at a crossroads. What’s next?

Thank you for your interest in STAT’s virtual event, “The 340B drug discount program is at a crossroads. What’s next?” 

You can find a recording of the event on our website here.

If you were able to participate in this virtual event please tell us what you thought by taking the quick survey below. We want to be sure we’re delivering insightful presentations that you find useful.

If you found today’s discussion insightful, we hope you’ll join us for our upcoming virtual event “The evolving landscape for biosimilars,” taking place September 30th at 1:00 p.m. ET.  STAT’s Ed Silverman will convene a discussion on what it will take to create a functioning biosimilar market in the U.S. Register for this virtual event here.